Kanaph Therapeutics Inc. (KOSDAQ:0082N0)
South Korea · Delayed Price · Currency is KRW 41,200
+4,100 (11.05%)
At close: Apr 1, 2026
Kanaph Therapeutics Market Cap
Kanaph Therapeutics has a market cap or net worth of 482.61 billion as of April 2, 2026.
Market Cap
482.61B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
41,200.00
Market Cap Chart
Since March 16, 2026, Kanaph Therapeutics's market cap has decreased from 655.58B to 482.61B, a decrease of -26.38%. That is a compound annual growth rate of -99.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 482.61B | -9.59% |
| Apr 1, 2026 | 533.79B | 11.05% |
| Mar 31, 2026 | 480.67B | -11.46% |
| Mar 30, 2026 | 542.86B | -9.41% |
| Mar 27, 2026 | 599.22B | 3.58% |
| Mar 26, 2026 | 578.49B | 13.90% |
| Mar 25, 2026 | 507.88B | -2.24% |
| Mar 24, 2026 | 519.54B | -7.18% |
| Mar 23, 2026 | 559.70B | -17.24% |
| Mar 20, 2026 | 676.30B | 14.98% |
| Mar 19, 2026 | 588.20B | -2.26% |
| Mar 18, 2026 | 601.81B | 1.64% |
| Mar 17, 2026 | 592.09B | -9.68% |
| Mar 16, 2026 | 655.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curocell | 709.93B |
| IntoCell | 626.00B |
| HansBiomed | 516.97B |
| Y-Biologics | 502.39B |
| S.Biomedics | 402.52B |
| TiumBio | 359.70B |
| curacle co.,ltd. | 325.74B |
| Kangstem Biotech | 316.02B |